
Industry Watch
In the first week of December, Industry Watch brings our readers news of promising developments in oncology. There’s a machine learning method being…
In the first week of December, Industry Watch brings our readers news of promising developments in oncology. There’s a machine learning method being…
In the third week of November, Industry Watch brings you news on the role played by gut microbiota in conditions such as Parkinson’s, MS, and…
With fall in the air in the northern hemisphere, it’s also a week full of noteworthy news in clinical development. New research shines a light on…
A recent study shows that a blood test can detect Alzheimer’s disease early in its progression. It’s as accurate as other more invasive, expensive…
PRA’s project team turned around a challenging neonatal seizure study to enable successful recruitment. The relationships between the sponsor and the…
Glioblastoma (GBM) is one of the most complex, deadly, treatment-resistant cancers that accounts for 48% of all primary malignant brain tumors. In…
Many people have heard of brain-related illnesses such as Alzheimer’s (ALZ). In honor of Brain Awareness Month, we shed some light on ALZ and other…
Onboarding is the process of welcoming new employees into an organization and providing them with the tools, resources, and knowledge to become…
Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…
Extended-release (ER) opioid formulations are often targeted for misuse and abuse because they contain high amounts of opioid. An oral…